NASDAQ:SCPH - Scpharmaceuticals Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $4.11 -0.99 (-19.41 %) (As of 11/16/2018 04:00 PM ET)Previous Close$5.10Today's Range$3.88 - $5.1452-Week Range$3.76 - $18.17Volume147,202 shsAverage Volume80,189 shsMarket Capitalization$94.70 millionP/E Ratio-0.51Dividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email scPharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix, a drug-device combination product that is under development for treatment of worsening or decompensated heart failure outside of the inpatient setting. Its product pipeline also includes scFurosemide, a loop diuretic for the management of edema in patients with decompensated heart failure; scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company was founded in 2013 and is headquartered in Burlington, Massachusetts. Receive SCPH News and Ratings via Email Sign-up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SCPH Previous Symbol CUSIPN/A Webwww.scpharma.com Phone617-517-0730 Debt Debt-to-Equity Ratio0.10 Current Ratio13.80 Quick Ratio13.80 Price-To-Earnings Trailing P/E Ratio-0.51 Forward P/E Ratio-2.12 P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book Value$6.02 per share Price / Book0.68 Profitability EPS (Most Recent Fiscal Year)($8.04) Net Income$-23,810,000.00 Net MarginsN/A Return on Equity-32.02% Return on Assets-27.64% Miscellaneous Employees29 Outstanding Shares18,570,000Market Cap$94.70 million OptionableNot Optionable Scpharmaceuticals (NASDAQ:SCPH) Frequently Asked Questions What is Scpharmaceuticals' stock symbol? Scpharmaceuticals trades on the NASDAQ under the ticker symbol "SCPH." How were Scpharmaceuticals' earnings last quarter? Scpharmaceuticals Inc (NASDAQ:SCPH) announced its quarterly earnings data on Tuesday, November, 13th. The company reported ($0.31) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.53) by $0.22. View Scpharmaceuticals' Earnings History. When is Scpharmaceuticals' next earnings date? Scpharmaceuticals is scheduled to release their next quarterly earnings announcement on Tuesday, March 19th 2019. View Earnings Estimates for Scpharmaceuticals. What price target have analysts set for SCPH? 3 Wall Street analysts have issued 1 year target prices for Scpharmaceuticals' stock. Their forecasts range from $12.00 to $14.00. On average, they anticipate Scpharmaceuticals' share price to reach $12.6667 in the next year. This suggests a possible upside of 208.2% from the stock's current price. View Analyst Price Targets for Scpharmaceuticals. What is the consensus analysts' recommendation for Scpharmaceuticals? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Scpharmaceuticals in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Scpharmaceuticals. Has Scpharmaceuticals been receiving favorable news coverage? Media headlines about SCPH stock have been trending positive on Friday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Scpharmaceuticals earned a news sentiment score of 2.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the immediate future. Who are some of Scpharmaceuticals' key competitors? Some companies that are related to Scpharmaceuticals include Achillion Pharmaceuticals (ACHN), ZEALAND PHARMA/S (ZEAL), Verastem (VSTM), Stemline Therapeutics (STML), Abeona Therapeutics (ABEO), Corbus Pharmaceuticals (CRBP), Cytokinetics (CYTK), American Brivision (Holding) (ABVC), Savara (SVRA), Seres Therapeutics (MCRB), Minerva Neurosciences (NERV), Merus (MRUS), Adamas Pharmaceuticals (ADMS), Aratana Therapeutics (PETX) and resTORbio (TORC). Who are Scpharmaceuticals' key executives? Scpharmaceuticals' management team includes the folowing people: Mr. John H. Tucker, Pres, CEO & Director (Age 55)Dr. Troy A. Ignelzi, Chief Financial Officer (Age 50)Mr. Abraham Ceesay, Chief Operating Officer (Age 40)Dr. Pieter Muntendam, Consultant (Age 60)Katherine Taudvin, Director of Corp. Devel. & Investor Relations When did Scpharmaceuticals IPO? (SCPH) raised $96 million in an initial public offering (IPO) on Friday, November 17th 2017. The company issued 6,400,000 shares at a price of $14.00-$16.00 per share. Jefferies, Leerink Partners and BMO Capital Markets served as the underwriters for the IPO. Who are Scpharmaceuticals' major shareholders? Scpharmaceuticals' stock is owned by a variety of of retail and institutional investors. Top institutional investors include AWM Investment Company Inc. (2.53%), JPMorgan Chase & Co. (0.12%) and JPMorgan Chase & Co. (0.12%). View Institutional Ownership Trends for Scpharmaceuticals. Which major investors are buying Scpharmaceuticals stock? SCPH stock was acquired by a variety of institutional investors in the last quarter, including AWM Investment Company Inc., JPMorgan Chase & Co. and JPMorgan Chase & Co.. View Insider Buying and Selling for Scpharmaceuticals. How do I buy shares of Scpharmaceuticals? Shares of SCPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Scpharmaceuticals' stock price today? One share of SCPH stock can currently be purchased for approximately $4.11. How big of a company is Scpharmaceuticals? Scpharmaceuticals has a market capitalization of $94.70 million. The company earns $-23,810,000.00 in net income (profit) each year or ($8.04) on an earnings per share basis. Scpharmaceuticals employs 29 workers across the globe. What is Scpharmaceuticals' official website? The official website for Scpharmaceuticals is http://www.scpharma.com. How can I contact Scpharmaceuticals? Scpharmaceuticals' mailing address is 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA, 01830. The company can be reached via phone at 617-517-0730 or via email at [email protected] MarketBeat Community Rating for Scpharmaceuticals (NASDAQ SCPH)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 76 (Vote Outperform)Underperform Votes: 66 (Vote Underperform)Total Votes: 142MarketBeat's community ratings are surveys of what our community members think about Scpharmaceuticals and other stocks. Vote "Outperform" if you believe SCPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SCPH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/16/2018 by MarketBeat.com StaffFeatured Article: Why is the conference call important?